Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 1 de 1
1.
Nihon Hinyokika Gakkai Zasshi ; 94(7): 701-4, 2003 Nov.
Article Ja | MEDLINE | ID: mdl-14672003

Interferon alpha (IFN-alpha) therapy was conducted for a male patient aged 70 years old, who underwent a two-stage radical nephrectomy for bilateral renal cell carcinoma with multiple pulmonary metastasis. He was hospitalized due to leg weakness and disorientation 45 days after this treatment was started. We discontinued INF-alpha therapy immediately after neurologists indicated the disorder of the central and the peripheral nervous systems induced by the administration of this cytokine. Steroid pulse therapy was effective to resolve the patient's neurological symptoms. To our knowledge, this is the first case of the side effects on both central and peripheral nervous systems by IFN-alpha therapy for renal cell carcinoma.


Antineoplastic Agents/adverse effects , Carcinoma, Renal Cell/drug therapy , Central Nervous System Diseases/chemically induced , Interferon-alpha/adverse effects , Kidney Neoplasms/drug therapy , Peripheral Nervous System Diseases/chemically induced , Aged , Central Nervous System Diseases/drug therapy , Humans , Male , Methylprednisolone/administration & dosage , Peripheral Nervous System Diseases/drug therapy , Pulse Therapy, Drug
...